 | |
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C25H24N2O2 |
| Molar mass | 384.479 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
QUCHIC (BB-22,SGT-32 or1-(cyclohexylmethyl)-1H-indole-3-carboxylic acid 8-quinolinyl ester) is adesigner drug offered by online vendors as a cannabimimetic agent, and was first detected being sold insynthetic cannabis products in Japan in early 2013,[1] and subsequently also in New Zealand.[2] The structure of QUCHIC appears to use an understanding ofstructure-activity relationships within the indole class of cannabimimetics, although its design origins are unclear. QUCHIC, along withQUPIC, represents a structurally unique synthetic cannabinoid chemotype since it contains an ester linker at the indole 3-position rather than the precedented ketone ofJWH-018 and its analogues, or the amide ofSDB-001 and its analogues.
BB-22 acts as afull agonist with abinding affinity of 0.217nM atCB1 and 0.338nM atCB2cannabinoid receptors.[3]
 | Thiscannabinoid related article is astub. You can help Wikipedia byexpanding it. |
